Clinical Trial: Sleeve Gastrectomy Vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06820047) titled 'Sleeve Gastrectomy Vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study' on Jan. 27.

Brief Summary: Obesity is a widespread and preventable condition affecting over a billion people globally, with rates expected to rise significantly by 2030. It increases the risk of chronic illnesses such as diabetes, cardiovascular disease, certain cancers, mental health issues, and premature death. While bariatric surgery, such as sleeve gastrectomy (SG), is the most effective long-term weight-loss solution, many individuals are ineligible or unwilling to undergo surgery. Semaglutide, a medication ...